The Impact of Glucagon-Like Peptide-1 Receptor Agonist on the Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis and Systematic Review

BACKGROUND: Since 2005, the cardioprotective effects of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) have garnered attention. The cardioprotective effect could be an added benefit to the use of GLP-1 RA. This systematic review and meta-analysis aimed at summarizing observational studies tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Ali, Alqaisi, Sura, Saith, Sunil E., Alzakhari, Rana, Levy, Ralph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409547/
https://www.ncbi.nlm.nih.gov/pubmed/37559715
http://dx.doi.org/10.14740/cr1523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409547/
https://www.ncbi.nlm.nih.gov/pubmed/37559715
http://dx.doi.org/10.14740/cr1523

Ejemplares similares